Table of Contents
We believe every great idea deserves the spotlight and the right support to grow. That’s why we’re excited to introduce you to a new group of innovative startups currently raising funds and ready to take their next big leap!
🤝 At Rundit, we empower startups seeking capital by introducing them to over 10,000 venture capitalists and 1,000+ angel investors globally! Our mission is to bolster the startup ecosystem, and investors frequently seek our recommendations for featured companies in this newsletter. If your company is fundraising and you would like to join us on the next newsletter – fill in this form!
If you’re interested in connecting with them, we’re happy to facilitate an introduction. Contact us at info@rundit.com!
| P3 Therapeutics | Croatia |
|---|
| Industry: Biotech |
| Round details: preclinical, pre revenue – €1.2M |
| Chronic immune-mediated inflammatory diseases (IMIDs), such as spondyloarthritis (SpA), arise from a complex mix of genetic, environmental, and immune system factors, leading to inflammation and tissue damage. Current treatments, especially second-line options, are limited, highlighting the urgent need for innovative therapies. Traditional drug discovery has focused on highly selective “magic bullet” drugs targeting single molecules, but this approach often falls short for complex diseases like SpA. To address this, we use a network pharmacology approach that targets multiple pathways simultaneously. Our novel strategy, Triple Target Activation (TTA), activates three key anti-inflammatory targets to restore immune balance. Supported by AI-driven drug design, this method aims to suppress chronic inflammation more effectively than single-target drugs. We have completed lead candidate optimization and secured funding for proof-of-concept studies, with plans for preclinical development pending additional investment. |
| CloudTop | Sweden |
|---|
| Industry: Deep Tech |
| Round details: €7M |
| CloudTop is a cloud-based Operating System created by the original founder of iCloud. As demand grows for data sovereignty, digital independence, and non-US deep tech, CloudTop delivers. It provides enterprises with a closed, sovereign environment for running in-house systems, enabling full collaboration between users, apps, and AI agents. CloudTop’s alpha launch is scheduled for fall 2025. |
| Minimass | United Kingdom |
|---|
| Industry: Construction |
| Round details: Seed – £2M |
| Minimass is a patented low-carbon and low-cost design and engineering solution revolutionising large-scale construction, with applications ranging from warehouses to bridges. Structural elements (e.g. beams & frames) are manufactured in an innovative way – using 3D concrete printing – using half the quantity of material vs traditional concrete or steel construction for equivalent performance. |
| Mykor | Portugal |
|---|
| Industry: Sustainable construction |
| Round details: Seed – £2,000,000 |
| Mykor develops and scales next-generation building insulation for planet and human health with advanced biotechnologies. Our products offer 100% bio-based and carbon-sequestering alternatives to conventional insulation with better performance and at comparative price points. We engineer our products for construction applications using industrial residues, mycelium biotechnology, and green chemistry. Mykor’s products respond to the new requirements for insulation materials of today that 92% of construction products on the market do not address: fire safety, circularity, and low embodied carbon. |
| Torram Labs Inc. | Canada |
|---|
| Industry: Blockchain / DeFi |
| Round details: Seed – $3M |
| TORRAM is building the rails for the future of institutional DeFi and RWAs using Bitcoin as a natively secured settlement layer. We’re making the Bitcoin blockchain more useful enabling companies/builders to build more robust applications that were not possible before on Bitcoin. Web3 Analogy: If Chainlink + the Graph had a Bitcoin-native baby, that’s us, TORRAM. |
| GlycanAge | Croatia |
|---|
| Industry: Biotech, Longevity |
| Round details: Series A – €5 million |
| GlycanAge is revolutionizing health-tech and longevity with advanced blood biomarkers developed from 30+ years of research and 200,000+ sample analyses. Leveraging the world’s largest proprietary dataset of the human glycome, GlycanAge is leading the way in predicting and preventing age-related conditions, beginning with menopause, cardiovascular disease, and neurodegenerative disorders. |
| AHILAB | United Kingdom |
|---|
| Industry: SaaS |
| Round details: Seed (MVP with tractions) – £650,000 |
| Gen AI apps are everywhere—305M users, 3M apps—but most can’t make money because they lack the right data. Founded by an ex-Meta Data Scientist and a Silicon Valley Software Engineer, Ahilab solves this problem by turning AI interactions into useful insights. Our first focus: monetization. We built the first ad network for Gen AI apps, placing relevant, data-driven ads inside AI-generated content—like Google Ads but optimized for AI. We started a Gen AI focused startup accelerator program in October 2024 and completed it last month. As of today, we process on average 525K API requests a month and are tapping into a $3.3B market. We are raising £650K in funding, to scale to £60K MRR and 5M monthly API requests. |
| Vegaaniruoka.fi (Veru Oy) | Finland |
|---|
| Industry: Online Marketplace |
| Round details: Pre-Seed – €100,000 |
| Vegaaniruoka is Finland’s biggest vegan food e-commerce, growing 35% quarterly with €2,625 monthly revenue. Our team’s 10+ combined years in e-commerce gives us a unique set of skills and experience to dominate the market. Seeking €100K pre-seed to scale marketing, expand across Nordics, targeting €200K ARR and €1-2M acquisition. Join us? |
| Akita® by Finnadvance Ltd. | Finland |
|---|
| Industry: Life Science |
| Round details: Seed – €3 million |
| We are enabling animal-free drug discovery using engineered microchips. With key patents granted and validation data from industry partners, we have shown 30% year-over-year growth with platforms delivered to 21 countries. |
| Phoenix Carbon | United Kingdom |
|---|
| Industry: Materials, Sustainability, Recycling |
| Round details: Seed – $1,2 million |
| Carbon fiber (CF) is unsustainable, emitting ~30T of CO₂ per tonne produced, with 62,000T landfilled annually. Recycling is limited by toxic methods and low value. Phoenix’s solution preserves CF’s original specs, enabling reuse at 50% lower cost with 87% lower emissions, supporting ESG goals. The global CF component market is $53B in the EU. Phoenix aims for 500T throughput in 3–5 years. |
| Lowr | United Kingdom |
|---|
| Industry: Climate/ Sports Tech/ B2B Saas |
| Round details: Pre-Seed – $750,000 |
| Lowr operates at the intersection of human connection and environmental impact, transforming the way people gather. From live events to global venues, we turn the largest carbon footprint—attendee travel—into insights and actions through gamified emissions reduction. |
Get featured in our newsletter and gain visibility to 10,000+ investors.
📅 Don’t miss out! Subscribe to our monthly roundup for the latest industry trends, funding opportunities, and exclusive insights – delivered straight to your inbox!
